In a letter to the FDA, participants of Congress point out complication over suppliers’ implementation of scientific choice assistance software program that is excluded from clinical tool policies and require quality from its Facility for Gadgets and Radiological Wellness.
发布者:Dr.Durant,转转请注明出处:https://robotalks.cn/lawmakers-ask-cdrh-to-revisit-its-cds-guidance/